Atlas Trials

A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

Clinical trial NCT00119600 · TERMINATED

Trial details

NCT number
NCT00119600
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AnemiaCancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.